Metagenomi Income Statement (2023-2025) | MGX

Income Statement Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 8.66M11.34M12.36M12.40M11.16M20.01M11.51M9.61M4.13M8.51M8.66M
Operating items
Research & Development 20.13M22.68M26.84M24.75M31.44M28.32M26.26M23.16M25.14M22.51M25.28M
Selling, General & Administrative 6.46M6.62M7.92M7.84M8.75M8.55M7.64M7.07M6.80M6.99M6.21M
Operating Expenses 26.59M29.30M34.76M32.59M40.19M36.87M33.90M30.24M31.95M29.50M31.50M
Operating Income -17.94M-17.96M-22.39M-20.20M-29.03M-16.86M-22.38M-20.62M-27.82M-20.99M-22.84M
EBIT -17.94M-17.96M-22.39M-20.20M-29.03M-16.86M-22.38M-20.62M-27.82M-20.99M-22.84M
Non-operating items
Interest & Investment Income 4.00M3.97M3.87M3.63M3.93M3.98M3.62M3.20M2.89M2.48M2.21M
Other Non Operating Income -0.00M0.02M-0.09M-0.00M-0.05M-0.05M-0.06M-0.05M-0.01M-0.07M-0.00M
Non Operating Income 4.00M6.85M3.78M3.63M3.88M3.92M1.50M-3.98M2.88M1.12M2.21M
Net income details
EBT -13.94M-11.11M-18.61M-16.57M-25.15M-12.94M-20.88M-24.61M-24.94M-19.86M-20.63M
Tax Provisions -2.20M1.90M1.21M2.73M-2.20M-2.11M-1.21M0.10M0.04M-0.23M
Profit After Tax -16.13M-13.01M-19.82M-19.29M-25.15M-10.74M-18.77M-23.40M-25.04M-19.91M-20.39M
Income from Continuing Operations -11.74M-13.01M-19.82M-19.29M-25.15M-10.74M-18.77M-23.40M-25.04M-19.91M-20.39M
Consolidated Net Income -11.74M-13.01M-19.82M-19.29M-25.15M-10.74M-18.77M-23.40M-25.04M-19.91M-20.39M
Income towards Parent Company -11.74M-13.01M-19.82M-19.29M-25.15M-10.74M-18.77M-23.40M-25.04M-19.91M-20.39M
Net Income towards Common Stockholders -16.13M-13.01M-19.82M-19.29M-25.15M-10.74M-18.77M-23.40M-25.04M-19.91M-20.39M
Additional items
EPS (Basic) -4.74-3.82-5.82-5.67-1.19-0.29-0.51-0.71-0.68-0.54-0.55
EPS (Weighted Average and Diluted) -4.74-3.82-5.82-5.67-1.19-0.29-0.51-0.71-0.68-0.54-0.55
Shares Outstanding (Weighted Average) 3.40M3.40M3.40M3.40M21.14M36.63M36.77M33.03M37.02M37.16M37.35M
Shares Outstanding (Diluted Average) 3.40M3.40M3.40M3.40M21.14M36.63M36.77M33.03M37.02M37.16M37.35M
EBITDA -16.11M-13.18M-19.75M-19.03M-25.33M-10.73M-16.87M-24.33M-25.13M-20.16M-20.39M
Tax Rate 15.76%-17.08%-6.48%-16.45%17.00%10.09%4.91%-0.39%-0.22%1.13%